Tone mix
Week by week 52 weeks
Share of Agios Pharmaceuticals, Inc.'s 143 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Jun 29, 2026 · tone -100Zacks Research Issues Negative Forecast for AGIO Earnings-118
- Week of Oct 12, 2026 · tone -100Agios Pharmaceuticals (NASDAQ:AGIO) Stock Gets Price Target Reduction from Truist Financial-100
- Week of Jul 20, 2026 · tone -67Agios Pharmaceuticals (NASDAQ:AGIO) Shares Gap Down Following Analyst Downgrade-82
- Week of Sep 28, 2026 · tone +100Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Stock Now Rated "Moderate Buy" by Sell-Side Brokerages+75
- Week of Jun 30, 2025 · tone +66Analysts Set Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Price Target at $58.60+74
- Week of Nov 3, 2025 · tone +100HC Wainwright Has Bullish Forecast for AGIO FY2025 Earnings+71
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Agios Pharmaceuticals, Inc. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 5 | 0 |
| Last 30 sessions | 9 | 0 |
| Last 90 sessions | 41 | +14 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Monday, October 26, 2026
4 headlines, average tone 0: 0 positive, 4 neutral and 0 negative. Showing all 4.
- www.tickerreport.com · 1 outletAgios Pharmaceuticals (NASDAQ:AGIO) Insider Sarah Gheuens Sells 1,489 Shares of StockNeutral
- www.dailypolitical.com · 1 outletAgios Pharmaceuticals (NASDAQ:AGIO) Insider Sarah Gheuens Sells 500 Shares of Company StockNeutral
- www.dailypolitical.com · 1 outletAgios Pharmaceuticals (NASDAQ:AGIO) Stock: Insider Sarah Gheuens Sells 1,489 SharesNeutral
- www.tickerreport.com · 1 outletInsider Selling: Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sells $18,760.00 in StockNeutral
Show the table · 4 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sarah Gheuens Sells 1,489 Shares of Stock | www.tickerreport.com | 1 | Neutral |
| Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sarah Gheuens Sells 500 Shares of Company Stock | www.dailypolitical.com | 1 | Neutral |
| Agios Pharmaceuticals (NASDAQ:AGIO) Stock: Insider Sarah Gheuens Sells 1,489 Shares | www.dailypolitical.com | 1 | Neutral |
| Insider Selling: Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sells $18,760.00 in Stock | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 23, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletContrasting Revolution Medicines (NASDAQ:RVMD) and Agios Pharmaceuticals (NASDAQ:AGIO)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Contrasting Revolution Medicines (NASDAQ:RVMD) and Agios Pharmaceuticals (NASDAQ:AGIO) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 12, 2026
1 headline, average tone -100: 0 positive, 0 neutral and 1 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletAgios Pharmaceuticals (NASDAQ:AGIO) Stock Gets Price Target Reduction from Truist FinancialNegative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Agios Pharmaceuticals (NASDAQ:AGIO) Stock Gets Price Target Reduction from Truist Financial | www.themarketsdaily.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 9, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletHead-To-Head Analysis: Agios Pharmaceuticals (NASDAQ:AGIO) and Incyte (NASDAQ:INCY)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head-To-Head Analysis: Agios Pharmaceuticals (NASDAQ:AGIO) and Incyte (NASDAQ:INCY) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 6, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletIncyte (NASDAQ:INCY) & Agios Pharmaceuticals (NASDAQ:AGIO) Critical ContrastNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Incyte (NASDAQ:INCY) & Agios Pharmaceuticals (NASDAQ:AGIO) Critical Contrast | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Agios Pharmaceuticals, Inc., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.